According to Nuvama, the increased competitive intensity following this approval is negative for Cipla, as it raises the risk to market share and peak sales expectations for its Advair inhaler ...
The shares of Cipla dropped nearly 2 percent to its day's high on January 13 after the US FDA granted its final approval to ...
The first generic version of the popular Advair asthma inhaler has been approved by U.S. regulators. The Food and Drug Administration on Wednesday approved Mylan’s version in three strengths for ages ...
APPLETON, Wis. -- A young Wisconsin man died from an asthma attack after the price of his inhaler skyrocketed nearly $500, according to a lawsuit filed by his family. From birth, Cole Schmidtknecht ...
LONDON (Reuters) - The prospect of generic copies of GlaxoSmithKline's best-selling lung drug Advair finally making it to market in the United States hit confidence in the drugmaker on Tuesday, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results